This article is more than 5 years old. Information may no longer be current.

Institute names associate director

Issue: July 25, 2013

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

John Deeken, MD, has been named the associate director of clinical research and medical oncology at Inova Comprehensive Cancer and Research Institute.

Deeken will help with the development, contracting and approval processes for clinical trials at Inova, based in Falls Church, Va. He also has been named a fellow of the Inova Translational Medical Institute, where he will help introduce genomic-based therapy into the cancer clinic.

Deeken previously served as the director of Georgetown Lombardi Cancer Center’s Head and Neck Medical Oncology Clinic.

 

John Deeken

“John has a depth of experience in early phase clinical research and shares my strong belief that in the near future we will study each patient genomically to be confident we are giving the right drug at the right dose to treat our cancer patients,” John E. Niederhuber, MD, CEO and director of Inova Comprehensive Cancer and Research Institute and CEO of the Inova Translational Medicine Institute, said in a press release.